Maravai LifeSciences Chairman Carl Hull Retires; R. Andrew Eckert Appointed Chairman

MARAVAI LIFESCIENCES HOLDINGS, INC.

Founder Carl Hull retires as Executive Chairman and resigns from Board, effective Dec 5, 2024; departure not related to any disagreement.
R. Andrew Eckert unanimously elected Chairman of the Board, effective Dec 5, 2024; he is a healthcare industry veteran with prior executive roles.
Eckert receives annual cash retainer of $175,000 (starting Jan 1, 2025) and RSU awards with total grant date fair value of $1.25M, subject to vesting.
Initial RSU award of $750K vests one-third immediately, remainder at 2025 annual meeting and one year later; second award of $500K expected at 2025 annual meeting.
Carl Hull founded Maravai in 2014, served as CEO until Oct 2022 when he became Executive Chairman.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.